Seeking Alpha

rh12297

rh12297
Send Message
View as an RSS Feed
View rh12297's Comments BY TICKER:
Latest  |  Highest rated
  • One Reason To Be Cautious On Priceline [View article]
    From a technical point of view (short term) it certainly does not look healthy. Your fundamental analysis is helpful.
    Mar 12, 2015. 05:15 PM | 3 Likes Like |Link to Comment
  • Is Priceline Eating Expedia's Lunch? [View article]
    We will all have a better idea as to PCLN's competitive position once they report on Feb 19th. I have been trading the ebbs and flows of PCLN via selling premium and should there be a change of trend will consider a directional position.
    Feb 7, 2015. 11:14 AM | 1 Like Like |Link to Comment
  • Priceline falls below $1,000 [View news story]
    From a technical standpoint, my views are that $1,000 is a good psychological support level for PCLN. We will know the prognosis when PCLN reports earnings in February. I for one will be monitoring the charts closely.
    Jan 16, 2015. 02:00 AM | Likes Like |Link to Comment
  • I'm Buying Priceline On The Way Down [View article]
    While that may be the case, I would prefer to wait for at least a re-test of the 50 DMA or at the very minimum a spike above the weekly pivot. Currently PCLN is trading below both the 50 and the 200 DMA and is far away from the weekly pivot.
    Jan 7, 2015. 03:11 PM | Likes Like |Link to Comment
  • Galectin Therapeutics: Why This Penny Stock Dressed Up By Stock Promoters Is A Short [View article]
    I wonder if GALT Investor Relations will release a press statement clarifying the issue - companies typically do.
    Jul 28, 2014. 03:02 PM | 1 Like Like |Link to Comment
  • Galectin Therapeutics: Why This Penny Stock Dressed Up By Stock Promoters Is A Short [View article]
    There seems to be a spate of such articles "watering down" up and coming biotech companies who attempt to make good progress. We all know that time will tell.
    Jul 28, 2014. 11:08 AM | 3 Likes Like |Link to Comment
  • New moniker for Star Scientific [View news story]
    Fortunately I only purchased 400 shares albeit a bit high at around $2.50. Well it was a calculated risk, one that I was prepared for. Let's hope it continues to entertain us.
    Jun 4, 2014. 07:09 AM | Likes Like |Link to Comment
  • NanoViricides: House Of Cards With -80% Downside, 'Strong Sell' Recommendation [View article]
    I for one will watch this situation play out. Only time will tell how this company will eventually fare.
    Feb 14, 2014. 04:27 PM | Likes Like |Link to Comment
  • Examining Inovio: Impact Of Roche Deal [View article]
    Kudos for a very informative and timely summary. Inovio does seem to have quite a lot of things in the pipeline, and I wil be eagerly watching their development with anticipation
    Sep 11, 2013. 09:17 AM | Likes Like |Link to Comment
COMMENTS STATS
9 Comments
8 Likes